Pollock, K. M., Cheeseman, H. M., Szubert, A. J., Libri, V., Boffito, M., Owen, D., Bern, H., McFarlane, L. R., O'Hara, J., Lemm, N., McKay, P., Rampling, T., Yim, Y. T. N., Milinkovic, A., Kingsley, C., Cole, T., Fagerbrink, S., Aban, M., Tanaka, M., Mehdipour, S., Robbins, A., Budd, W., Faust, S., Hassanin, H., Cosgrove, C. A., Winston, A., Fidler, S., Dunn, D., McCormack, S., Shattock, R. J., , , Adams, K., Amini, F., Atako, N. B., Bakri, A., Barclay, W., Brodnicki, E., Brown, J. C., Byrne, R., Chilvers, R., Coelho, S., Day, S., Desai, M., Dorman, E., Elliott, T., Flight, K. E., Fletcher, J., Galang, J., Gohil, J., Gupta, A., Harlow, C., Hu, K., Kalyan, M., Lagrue, D., Liscano, E., Njenga, C., Polra, K., Powlette, D. A., Randell, P., Rauchenberger, M., Redknap, I., Ricamara, M., Rogers, P., Sallah, H., Samnuan, K., Schumacher, M., Shah, Z., Shaw, R., Shaw, T., Sivapatham, S., Slater, S., Sorley, K., Storch, R., Tan, E., Tan, T., Thielemans, L., Whitely, S., Valentine, C., Varghese, J., Vikraman, A., & Wilkins, M. (2022). safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial. EClinicalMedicine, 44, . http://access.bl.uk/ark:/81055/vdc_100180561188.0x000001